|
|
 |
 | Medical News Releases > University Groups > School of Medicine > Surgery >

Surgery: Urologic

| News Stories & Tip Sheets: |
Showing Stories 1 through 7 of 7.
- Show Home
|
 |
Lowering the risk for prostate cancer
 Drug reduces prostate cancer diagnosis in men at high risk

April 28,
2009 -- A drug widely used to shrink enlarged prostates has been shown to lower the risk of prostate cancer by 23 percent in men who have an increased risk of the disease, according to results of an international clinical trial presented April 27 at the American Urological Association annual meeting in Chicago.

|
Life-expectancy may rule out need for prostate cancer screening
 U.S. trial shows no early mortality benefit from annual prostate cancer screening

March 18,
2009 -- The prostate cancer screening tests that have become an annual ritual for many men don't appear to reduce deaths from the disease, at least among those with a limited life-expectancy, according to early results of a major U.S. study involving 75,000 men.

|
Surgery with less pain, blood
 New for kidney cancer: robotic surgery

June 27,
2008 -- Surgery to remove a kidney tumor is no longer a hands-on operation. Sam Bhayani, a urologic surgeon at the school of Medicine, has pioneered robotic surgery for kidney cancer. Instead of standing for hours with his arms raised above the patient, Bhayani sits at a nearby computer console to maneuver joystick-like controls that guide robotic scalpels, scissors and high-resolution cameras.

|
Professorship appointment
 Humphrey named Ladenson Professor of Pathology

Oct. 5,
2007 -- Peter Humphrey, M.D., Ph.D., has been named the Ladenson Professor of Pathology in the Department of Pathology and Immunology at the School of Medicine. The announcement was made by Larry Shapiro, M.D., executive vice chancellor for medical affairs and dean of the School of Medicine.

|
Two tests better than one
 Prostate cancer screening practices examined

March 16,
2005 -- Initial results from an ongoing study evaluating the benefit of prostate cancer screening practices demonstrate that the combined use of both standard tests—the prostate-specific antigen (PSA) blood test and the digital rectal exam (DRE)—is optimal for detecting cancer.

|
Finding the right PSA number
 Though not perfect, blood test for prostate cancer is still recommended

Nov. 29,
2004 -- The prostate-specific antigen (PSA) test is a common way to detect prostate cancer in its earliest stages. The exact number of a dangerously high PSA count is constantly under debate and varies among men in different age groups. Despite its imperfections, WUSM urologic surgeon Arnold Bullock still recommends the test be taken annually by men over 50.

|
Science meets science fiction
 Newly grown kidneys sustain life in rats

June 22,
2004 -- Growing new organs to take the place of damaged or diseased ones is moving from science fiction to reality, according to researchers at Washington University School of Medicine in St. Louis. Scientists have previously shown that embryonic tissue transplants can be used to grow new kidneys inside rats. In their latest study, though, they put the new kidneys to an unprecedented and critical test, removing the rat's original kidneys and placing the new kidneys in position to take over for them. The new kidneys were able to successfully sustain the rats for a short time.

|
Showing Stories 1 through 7 of 7.
- Show Home
|
 |
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
|  |
|
|  |  |
|